Clinical Trial Update: A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

View source ↗

Summary

A terminated clinical trial investigating the genetic basis of how children with idiopathic short stature respond to growth hormone treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Short Stature

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Idiopathic Short Stature | Status: TERMINATED